Tru Independence LLC Alkermes Plc. Put Options Transaction History
Tru Independence LLC
- $309 Million
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ALKS
# of Institutions
390Shares Held
169MCall Options Held
210KPut Options Held
137K-
Black Rock Inc. New York, NY29.1MShares$914 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$572 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.3MShares$385 Million0.04% of portfolio
-
State Street Corp Boston, MA8.81MShares$277 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.56MShares$237 Million3.55% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.16B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...